BWM
GILD icon

BlackDiamond Wealth Management’s Gilead Sciences GILD Stock Holding History

BlackDiamond Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
2,367
+637
+37% +$89.2K 0.16% 127
2025
Q4 		$262K Sell
1,730
-532
-24% -$64.7K 0.13% 163
2025
Q3 		$251K Buy
2,262
+431
+24% +$49K 0.14% 148
2025
Q2 		$205K Buy
+1,831
New +$195K 0.12% 159

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackDiamond Wealth Management's GILD Position: Q1 2026 in Review

BlackDiamond Wealth Management increased its Gilead Sciences (GILD) stake by 37% in Q1 2026, buying an estimated $89.2K and bringing the position to 2,367 shares worth $330K. The position accounts for 0.16% of the portfolio, ranked #127.

BlackDiamond Wealth Management first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • BlackDiamond Wealth Management held 2,367 shares of Gilead Sciences worth $330K as of Q1 2026.
  • BlackDiamond Wealth Management bought 637 Gilead Sciences shares in Q1 2026, an estimated $89.2K.
  • Gilead Sciences made up 0.16% of BlackDiamond Wealth Management's portfolio in Q1 2026, its #127 holding.
  • BlackDiamond Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.